Evidence map›Paper›PMID 36688971›Full record

ArticleEuropean radiology2023

Ultralow-dose [

Hui Tan, Chi Qi, Yanyan Cao, Danjie Cai, Wujian Mao, Haojun Yu, Xiuli Sui, Guobing Liu, Hongcheng Shi

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Total-bodyEJNMMI research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Expert consensus on workflow of PET/CT with long axial field-of-view.European journal of nuclear medicine and molecular imaging · 2025
    Review
  8. Article
  9. Article
  10. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  11. Article
  12. Quantitation of dynamic total-body PET imaging: recent developments and future perspectives.European journal of nuclear medicine and molecular imaging · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hui Tan *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Chi Qi *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Yanyan CaoDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Danjie CaiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Wujian MaoDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Haojun YuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Xiuli SuiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Guobing LiuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180 in Fenglin Road, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn.

Funding

Clinial Research Plan of Shanghai Hospital Development Centre SHDC2020CR3079BNational Science Foundation for Scholars of China Grant No. 81901796Outstanding Young Talents Program of Fudan Zhongshan Hospital 2021ZSYQ30Science and Technology Innovation Plan Of Shanghai Science and Technology Commission 19YF1408300Scientific research project of Shanghai Municipal Health Commission 20214Y0307Shanghai Municipal Key Clinical Specialty Project SHSLCZDZK03401
6 · The paper itself

Abstract

objectivesValidation of [

methodsThis prospective head-to-head intraindividual study compared dynamic and static parameters of ultralow-dose with half-dose [

resultsThirty participants were included in this study, and in terms of kinetic indicators, no special differences were found between the two groups of normal organs and lesions. In static images, those in groups ULD8 and LD2 achieved scores of [Formula: see text] 3.0, meeting the requirements for clinical diagnosis. In static imaging, four lesions were missed in the LD1 group with a lesion detectability of 89.7% (35/39). In the meantime, lesions were not missed in the whole ultra-low dose group (ULD5, ULD8, ULD10, and ULD15) and half-dose groups (LD2 and LD3).

conclusionsCompared with half-dose imaging, ultralow-dose [

trial registrationClinicalTrials.gov identifier: ChiCTR2000036487 KEY POINTS: • A prospective single-center study showed that the total-body PET scanner allows ultralow-dose [

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyFeasibility StudiesHumansPositron-Emission TomographyProspective StudiesTomography, X-Ray ComputedFluorodeoxyglucose F18Dose reductionFluorodeoxyglucose F18KineticsPET-CTTotal body

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.